View the full release here: https://www.businesswire.com/news/home/20191118005502/en/
- View the full release here: https://www.businesswire.com/news/home/20191118005502/en/
Pulmonx Announces that UnitedHealthcare, the Largest Commercial Insurer in the United States, Has Lifted Coverage Restrictions on the Zephyr Valve, a Minimally-Invasive Treatment Option for Severe Emphysema / COPD (Photo: Pulmonx Corporation)
UnitedHealthcare is the largest commercial health insurer in the United States covering more than 44.8 million members.
- As of October 1, 2019, UnitedHealthcare no longer considers endobronchial valve procedures unproven, when used in appropriate patients.
- With these coverage updates, the Zephyr Valve is now an available treatment option for over 77 million Americans with commercial insurance.
- Pulmonx Corporation is a medical device company that provides minimally-invasive solutions to treat patients with severe emphysema, a form of COPD.